Goldman Sachs Group »

Springworks Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 461k 36.50
2023-09-30 $14M 593k 23.12
2023-06-30 $24M 907k 26.22
2023-03-31 $12M 461k 25.74
2022-12-31 $9.9M 382k 26.01
2022-06-30 $6.7M 271k 24.62
2022-03-31 $13M 223k 56.44
2021-12-31 $14M 222k 61.98
2021-09-30 $14M 217k 63.44
2021-03-31 $10M 140k 73.57
2020-12-31 $25M 346k 72.52
2020-09-30 $423k 8.9k 47.63
2020-06-30 $2.0M 47k 42.01
2019-09-30 $1.1M 51k 21.67